Change 5-day change 1-year change 3-year change Capi.($)
-1.37%+8.35%+94.20%+133.06% 1,098B
-0.77%+2.12%+49.89%+50.90% 631B
+0.85%+2.04%+26.28%+65.14% 438B
-1.13%+3.62%+49.72%+38.22% 368B
-0.74%+1.09%+33.81%+38.95% 298B
-1.22%+2.99%+8.44%+6.11% 251B
-0.70%+9.35%+43.74%+58.09% 226B
+0.34%+1.62%-4.91%-50.77% 209B
+2.04%+3.52%+13.70%+69.71% 165B
Average +0.01%+1,657.21%+34.98%+45.49% 409.37B
Weighted average by Cap. +0.09%+1,331.50%+51.03%+67.30%
Logo Shire
Shire specializes in developing, producing, and marketing pharmaceutical products for the treatment of nervous system dysfunctions (hyperactivity, epilepsy, Alzheimer's disease, etc.), cancer, gastro-intestinal illnesses, and infectious diseases. Net sales break down by source of income as follows: - sales of products (95.3%); - other (4.7%): primarily franchise royalties. Net sales break down geographically as follows: the United States (63.6%), Ireland (0.4%) and other (36%).
Employees
-